Emilie Martin, S. Morisset, M. Sobh, A. Quillon, Hélène Boyer, P. Rey, E. Virelizier, S. Assaad, Amine Belabri, Y. Guillermin, L. Lebras, V. Mialou, J. Bourgeot, Mélinda Teyssier, M. Brahimi, S. Osmani, K. Amani, S. Bouchama, L. Charef, N. Yafour, A. Michallet, M. Bekadja, M. Michallet
{"title":"不同的治疗策略和财政资源如何影响骨髓瘤自体干细胞移植的结果?在法国和阿尔及利亚学习","authors":"Emilie Martin, S. Morisset, M. Sobh, A. Quillon, Hélène Boyer, P. Rey, E. Virelizier, S. Assaad, Amine Belabri, Y. Guillermin, L. Lebras, V. Mialou, J. Bourgeot, Mélinda Teyssier, M. Brahimi, S. Osmani, K. Amani, S. Bouchama, L. Charef, N. Yafour, A. Michallet, M. Bekadja, M. Michallet","doi":"10.1016/s2152-2650(23)00802-9","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"POSTER: MM-074 How can Different Therapeutic Strategies and Financial Resources Impact Outcomes After Autologous Stem Cell Transplantation in Myeloma? Study in France and Algeria\",\"authors\":\"Emilie Martin, S. Morisset, M. Sobh, A. Quillon, Hélène Boyer, P. Rey, E. Virelizier, S. Assaad, Amine Belabri, Y. Guillermin, L. Lebras, V. Mialou, J. Bourgeot, Mélinda Teyssier, M. Brahimi, S. Osmani, K. Amani, S. Bouchama, L. Charef, N. Yafour, A. Michallet, M. Bekadja, M. Michallet\",\"doi\":\"10.1016/s2152-2650(23)00802-9\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":10370,\"journal\":{\"name\":\"Clinical Lymphoma Myeloma and Leukemia\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Lymphoma Myeloma and Leukemia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/s2152-2650(23)00802-9\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Lymphoma Myeloma and Leukemia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s2152-2650(23)00802-9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
POSTER: MM-074 How can Different Therapeutic Strategies and Financial Resources Impact Outcomes After Autologous Stem Cell Transplantation in Myeloma? Study in France and Algeria